Cargando…
D-Serine: A Cross Species Review of Safety
Background:D-Serine, a direct, full agonist at the D-serine/glycine modulatory site of the N-methyl-D-aspartate-type glutamate receptors (NMDAR), has been assessed as a treatment for multiple psychiatric and neurological conditions. Based on studies in rats, concerns of nephrotoxicity have limited D...
Autores principales: | Meftah, Amir, Hasegawa, Hiroshi, Kantrowitz, Joshua T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384137/ https://www.ncbi.nlm.nih.gov/pubmed/34447324 http://dx.doi.org/10.3389/fpsyt.2021.726365 |
Ejemplares similares
-
D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?
por: MacKay, Mary-Anne B., et al.
Publicado: (2019) -
Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer
por: Guercio, Gerson D., et al.
Publicado: (2018) -
An Overview of the Involvement of D-Serine in Cognitive Impairment in Normal Aging and Dementia
por: Orzylowski, Magdalena, et al.
Publicado: (2021) -
Relationship of Brain Glutamate Response to D-Cycloserine and Lurasidone to Antidepressant Response in Bipolar Depression: A Pilot Study
por: Dong, Zhengchao, et al.
Publicado: (2021) -
Impairment of Executive Functions Associated With Lower D-Serine Serum Levels in Patients With Schizophrenia
por: Hons, Jaromir, et al.
Publicado: (2021)